The Long-Term Effects of Lexapro: What Happens to Your Brain and Body?

What Are the Long Term Side Effects of Lexapro (Escitalopram)?

The long term effects of Lexapro (escitalopram) come from the brain adapting to the drug's sustained presence. That can mean physical dependence, withdrawal symptoms when the dose drops, and symptoms that reappear on an unchanged dose, which some clinicians call tolerance. Continuing or stopping is your call, with your clinician.

Most people asking about Lexapro (escitalopram) long term did not plan to be on it this long. The prescription was written during a hard year, at 24, or after a birth, or when a parent died, and the years went by. The person who started the medication is not the same person now reading about it. That is worth naming, because the question "what does Lexapro do to your brain" is really a question about what has changed, what stays changed, and what happens if anything is altered. This piece looks at what long term lexapro use does inside the body, what is known about stopping, and where a clinician-guided hyperbolic taper fits into that conversation.

Understanding How Lexapro Affects Your Brain Long Term: What Does Lexapro Do to Your Brain?

Escitalopram binds to the serotonin transporter (SERT). Brain imaging shows that SSRIs occupy roughly 80% of serotonin transporters at their minimum therapeutic doses, with occupancy rising steeply at low doses and flattening at higher ones (Meyer et al., 2004). The relationship between dose and SERT occupancy for escitalopram is hyperbolic rather than straight-line (Horowitz & Taylor, 2024).

What matters for long term lexapro use is what the brain does in response. Faced with a target that is continuously occupied, the nervous system adapts: receptor sensitivity and expression shift, and the system settles into a new working state that assumes the drug is present. This adaptation is the mechanism behind most long term side effects of Lexapro, including the difficulty many people meet when a dose is lowered. It is not a sign of a personal flaw, and it is not evidence of a chemical imbalance being corrected; the chemical imbalance account of depression has never been established, and it is not how these effects are best explained (Moncrieff et al., 2023).

Dr. Mark Horowitz, who co-founded Outro Health, and Professor David Taylor set out the pharmacology in The Lancet Psychiatry: because each milligram has a larger effect at low doses than at high ones, reductions have to get progressively smaller to change the drug's effect in even steps (Horowitz & Taylor, 2019).

Lexapro Side Effects Long Term: What People Report While Still Taking It

Ongoing effects reported during extended treatment include emotional blunting, sexual difficulties, sleep changes, sweating and weight change (Horowitz & Taylor, 2024). Emotional blunting has been described both in surveys of people treated for depression (Goodwin et al., 2017) and in a double-blind, placebo-controlled study in healthy volunteers given escitalopram, which found specific changes in reinforcement sensitivity (Langley et al., 2023). That second design matters: it separates a drug effect from the condition being treated.

Sexual difficulties during treatment are well documented (Serretti & Chiesa, 2009), and a minority of people describe sexual difficulties persisting after stopping, now discussed as post-SSRI sexual dysfunction (Healy, 2020; Reisman, 2020). Population cohort work also reports associations between antidepressant use and cardiovascular and other adverse outcomes (Bansal et al., 2022). These are observational associations with residual confounding possible; they do not establish causation, but they are part of an honest account of lexapro side effects long term.

What Is Lexapro Tolerance?

Tolerance describes the same adaptation seen from another angle: the nervous system adjusts to the sustained presence of the drug, and the state it settles into differs from the state it was in when treatment began. In practice, people describe symptoms reappearing while the dose has not changed.

Two things follow. First, a symptom that reappears is not automatically relapse. Second, what gets recorded in a chart as a recurrent episode is sometimes tolerance, and sometimes withdrawal from a reduction made faster than the nervous system could follow (Horowitz & Taylor, 2024). Sorting between those possibilities is a clinical conversation, not something to work out alone.

Can Lexapro Stop Working?

People do report that symptoms come back during extended treatment, and clinicians have described this pattern in the literature for decades. We do not offer a verdict on how well escitalopram works for anyone; that is outside what this article can responsibly say. What the pharmacology supports is narrower and more useful: the brain adapts to continuous occupancy of the serotonin transporter, and adaptation can change how a person feels on an unchanged dose (Horowitz & Taylor, 2024).

If that is happening, the useful next step is a review with the clinician, who can look at timing, at any recent dose or formulation changes, at sleep, alcohol and other medications, and at whether symptoms track dose changes in a way that points toward withdrawal rather than a relapse.

Does Lexapro Build Tolerance Over Time?

Adaptation at the receptor level during extended exposure is well documented, and it can explain why some people report symptoms reappearing or find their dose increased over the years (Horowitz & Taylor, 2024). The nervous system is continuously adjusting to the drug. There is also a hypothesis, not yet established, that long term antidepressant exposure may itself contribute to persistent low mood in some people through this ongoing adaptation (El-Mallakh et al., 2011). It remains a plausible mechanism under investigation.

Can Lexapro Cause Depression?

What you are feeling is real, and nothing here suggests otherwise. The more defensible framing is that worsening low mood, or low mood that reappears, during long term lexapro use has several possible explanations that look alike from the outside: relapse, life circumstances, tolerance, or withdrawal following a dose change. NICE notes that withdrawal can include low mood, anxiety and tearfulness, and that relapse does not usually appear within days of a dose reduction (NICE, 2022). Withdrawal can also be delayed, first appearing several weeks or months after a dose reduction or the last dose, so late symptoms are not automatically relapse (Horowitz & Taylor, 2024).

The timing is the most informative clue a person and their clinician have. Symptoms that begin within days of a reduction, that include dizziness or electric-shock sensations, and that settle when the previous dose is restored point toward withdrawal rather than relapse. Symptoms that begin weeks later can still be withdrawal (Horowitz & Taylor, 2022), as the section on delayed onset withdrawal below explains.

Does Lexapro Change Your Brain Permanently? Long-Term Effects of Lexapro on Brain Function

Adaptations to long term antidepressant exposure can persist after the drug is gone. The Maudsley Deprescribing Guidelines summarize PET imaging showing altered serotonergic receptor sensitivity for months and years after antidepressants are stopped, and this is the leading explanation for protracted withdrawal (Horowitz & Taylor, 2024). Animal work points the same way.

"Permanent" overstates what is known. The better-supported statement about the long-term effects of Lexapro on brain function is that adaptation is real, that reversal takes time on a scale of months rather than days, and that recovery is described in the long term. If you want the recovery side of this in detail, we cover it in does your brain go back to normal after antidepressants. The practical consequence is about pace: a nervous system that took years to adapt is not asked to unadapt in a couple of weeks.

The Reality of Lexapro Withdrawal

Withdrawal is the clearer window onto long term lexapro side effects, because it shows what the brain had been compensating for. It is also the point where "discontinuation syndrome" gets used. The more accurate and honest term is antidepressant withdrawal; "discontinuation syndrome" is a pharmaceutical-industry euphemism that shifts responsibility for the difficulty of stopping from the drug to the patient.

How Common, How Severe, How Long

Withdrawal is highly individual. Some people have mild symptoms for days or weeks. Many have prolonged symptoms, often mistaken for relapse. In a 2019 systematic review across 14 studies, an average of 56% of people who stopped antidepressants experienced withdrawal effects, with a range of 27% to 86%, and in the four large studies measuring severity, an average of 46% of those who had withdrawal rated it at the most severe level offered (Davies & Read, 2019). In a 2025 survey of 310 NHS primary-care patients who had tried to stop an antidepressant, 79% reported withdrawal symptoms, 45% rated them moderately severe or severe, 20% had symptoms lasting more than three months and 10% for more than a year (Horowitz et al., 2025; the survey had an 18% response rate).

For escitalopram specifically, 15% to 22% of patients experienced a withdrawal syndrome after 24 weeks of treatment at 5mg to 20mg, and in a self-selected survey of people on long-term antidepressants conducted by the Royal College of Psychiatrists, 75% of those who stopped escitalopram reported withdrawal effects (Horowitz & Taylor, 2024).

Risk Factors

• Longer time on the drug
• Higher dose
• Shorter half-life medications
• A previous difficult attempt at stopping
• Stopping quickly or in large steps

A 2023 review found that longer use, SNRIs and paroxetine, and past withdrawal experience are associated with higher risk, with dose showing a weaker association (Horowitz et al., 2023). In the 2025 primary-care survey, people who had taken antidepressants for more than two years before stopping were far more likely to have a withdrawal syndrome, and severe withdrawal, than those who had taken them for under six months.

"One of the risk factors for severe withdrawal is duration of use."
Dr. Mark Horowitz, Clinical Co-Founder of Outro Health (Psychology Today, 2025)

Half-Life Is Not the Whole Timeline

Escitalopram has a half-life of about 30 hours and reaches peak plasma levels around four hours after a dose (Horowitz & Taylor, 2024). Clearance shapes when acute symptoms start, usually within a few days of a reduction, though for some people symptoms are delayed by weeks or months. It does not tell you when they end. The drug leaving the body does not mean the brain's adaptations have reversed, so prolonged withdrawal remains possible well after the last dose has cleared. Timeline detail by symptom is in our guide to Lexapro withdrawal symptoms.

Withdrawal or Relapse?

This distinction changes what happens next, which is why it deserves its own section. NICE advises that relapse does not usually occur as soon as someone stops or lowers an antidepressant, and that withdrawal can include symptoms atypical of depression, such as dizziness or electric-shock sensations (NICE, 2022). Withdrawal symptoms also tend to ease rapidly if the previous dose is reinstated under clinical guidance.

Delayed Onset Withdrawal

Withdrawal does not always start within a few days. Symptoms can first appear several weeks or even months after a dose reduction or the last dose, often called delayed onset withdrawal. It is best known with fluoxetine, whose active metabolite norfluoxetine stays in the body for weeks, but it is also seen with shorter-acting SSRIs such as escitalopram and with SNRIs. One hypothesis in the Maudsley Deprescribing Guidelines is that occupancy of the serotonin transporter in the brain falls more slowly than drug levels in the blood (Horowitz & Taylor, 2022, 2024). Studies reporting duration also show that withdrawal often lasts well beyond two weeks (Davies & Read, 2019; Horowitz et al., 2023).

This matters because late symptoms are easily read as relapse or as a new illness. It also affects pacing: Horowitz and Taylor suggest waiting about four weeks after an SSRI reduction to watch for late effects before judging how it went (Horowitz & Taylor, 2019). If symptoms start after a dose change, even weeks later, ask your clinician to consider withdrawal before concluding it is relapse.

Where relapse is the concern, it is worth holding one more finding in view: most people recover from depression within a year, including those with severe depression (Whiteford et al., 2013). That does not tell anyone what to do with their medication. It does mean that fear of a permanent condition should not be the only factor in a conversation about long term lexapro use.

Can You Be on Lexapro for Life?

Some people stay on an antidepressant for decades; others reduce or stop. Neither path is prescribed here. What we can say is that the decision belongs to you and your clinician, and that it is a decision, not a default. UK guidance advises that people treated for extended periods have the long-term usefulness of the medication re-evaluated periodically (NICE, 2022). Guidelines commonly reference a defined period of continuation after an episode, with longer continuation where episodes recur; a clinician applies that to the individual.

Points people bring to a review in favor of continuing as they are:

• Current symptoms feel well managed and side effects are tolerable
• Life is unusually demanding right now and stability matters more than change
• Past attempts to reduce were difficult and the support available then was thin
• Other treatment is in place and changing one variable at a time makes sense

Points people bring to a review in favor of revisiting the plan:

• Side effects such as emotional blunting or sexual difficulties now weigh heavily
• Symptoms have reappeared on an unchanged dose
• The original reason for the prescription no longer describes their life
• They want to reduce while they have support available, knowing longer use is associated with harder withdrawal

What a Supported Lexapro Taper Looks Like

If a reduction is agreed with a clinician, the shape matters more than the calendar. NICE advises tapering in steps where each dose is a proportion of the previous one, with smaller reductions and liquid formulations as the dose gets lower (NICE, 2022). Peer-led tapering communities found through years of trial and error that reductions of about 10% of the most recent dose, each smaller than the last, were the most helpful, and that pattern closely approximates the hyperbolic schedules derived from receptor-occupancy data (Horowitz & Taylor, 2024).

The repeated cycle described in the Maudsley Deprescribing Guidelines works like this:

1. A clinician estimates withdrawal risk from history, duration of use and past attempts, and sizes the first reduction to it.
2. Symptoms are monitored after the reduction, with time allowed for them to settle.
3. The next reduction is sized by how tolerable the last one was, and paused or reversed if it was not.
4. Steps continue until the dose is small enough that the final step to zero is no larger, in receptor-occupancy terms, than the steps already tolerated.

Final doses are far below the smallest tablet, which is why liquid escitalopram or compounded doses are used. These figures are illustrative and attributed to the guidelines; a clinician individualizes the plan. Do not stop escitalopram suddenly or change the dose without clinical support. If you are in crisis or thinking about harming yourself, call or text 988 in the US, or see our crisis resources.

Conclusion

The long term side effects of Lexapro are best understood as one process seen from several angles. The brain adapts to continuous occupancy of the serotonin transporter; that adaptation underlies emotional blunting and other ongoing effects, underlies tolerance and symptoms that reappear on an unchanged dose, and underlies withdrawal when the dose falls. The adaptation persists for a while after the last dose, which is why timelines are measured in months rather than by half-life.

None of this says what you should do. It says that if a change is being considered, the pace and the shape of that change are the parts most within anyone's control, and that they are decided with a clinician who can tell withdrawal from relapse.

How Outro Health Approaches Long Term Lexapro Use

Outro Health is a telehealth clinic for people who want to come off an antidepressant with clinical support. Our clinicians are trained in hyperbolic tapering, take over the prescription during the taper, monitor withdrawal symptoms between visits, and work with compounding pharmacies when doses smaller than the available tablets are needed. Outro Health's tapering program is currently available to patients in more than a dozen states, including California, Florida, New York, Texas and more. The information here is offered freely to anyone reading from anywhere. If you would like to find out whether an evaluation fits your situation, you can read about the Taper Management Program. You do not need to have made a decision to start learning about this.